Related Experiment Videos
Human immunodeficiency virus type 1 reverse transcriptase. Affinity labeling of the primer binding site
R L Mitina1, S V Doronin, M I Dobrikov
1Novosibirsk Institute of Bioorganic Chemistry, Siberian Division of the Russian Academy of Sciences.
FEBS Letters
|November 9, 1992
Summary
Researchers modified the primer site of HIV-1 reverse transcriptase (RT) using a photoreactive oligonucleotide derivative. This method allowed for targeted modification and inactivation of the enzyme, aiding in understanding its primer binding mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Human Immunodeficiency Virus type 1 reverse transcriptase (HIV-1 RT) is a key enzyme for viral replication.
- Understanding the interaction between HIV-1 RT and its primer is crucial for developing antiviral therapies.
- Affinity labeling is a technique used to study enzyme-ligand interactions.
Purpose of the Study:
- To perform affinity modification of the primer site of HIV-1 RT.
- To characterize the interaction between HIV-1 RT and oligonucleotide primers.
- To develop a method for selective inactivation of HIV-1 RT.
Main Methods:
- Synthesis of an oligonucleotide derivative with a photoreactive azido group.
- Enzyme kinetics studies to determine Michaelis constants (Km) for primer binding.
- UV-irradiation to induce photoaffinity labeling and enzyme inactivation.
- Primer extension assays and protection experiments to demonstrate selectivity.
Main Results:
- The affinity of HIV-1 RT for the modified primer was quantified using kinetic parameters.
- UV-irradiation in the presence of the photoreactive primer derivative led to enzyme inactivation.
- The rate of inactivation correlated with the primer concentration and Km value.
- Selective modification was confirmed by primer elongation and protection experiments.
Conclusions:
- The study successfully employed an oligonucleotide derivative for affinity modification of the HIV-1 RT primer site.
- This approach provides a tool for studying enzyme-primer interactions and for selective enzyme inactivation.
- The findings contribute to a deeper understanding of HIV-1 RT's catalytic mechanism and potential therapeutic targets.